Mitochondrial anchoring of PKCα by PICK1 confers resistance to etoposide-induced apoptosis

Springer Science and Business Media LLC - Tập 12 Số 10 - Trang 1857-1871 - 2007
Wei Li Wang1, Sheau Farn Yeh2, Eagle Yi Kung Huang3, Yu Lü1, Chun Fa Wang1, Chi Ying F. Huang1,4, Wey Jinq Lin5,1
1Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan, ROC
2Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan, ROC
3Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan, ROC
4National Institute of Cancer Research, National Health Research Institute, Taipei, Taiwan, ROC
5Department of Education and Research, Taipei City Hospital, Taipei, Taiwan, ROC

Tóm tắt

Từ khóa


Tài liệu tham khảo

Nakashima S, Protein kinase C (2002) alpha (PKC alpha): regulation and biological function. J Biochem (Tokyo) 132:669–675

Ng T, Squire A, Hansra G et al (1999) Imaging protein kinase Calpha activation in cells. Science 283:2085–2089

Vallentin A, Prevostel C, Fauquier T, Bonnefont X, Joubert D (2000) Membrane targeting and cytoplasmic sequestration in the spatiotemporal localization of human protein kinase C alpha. J Biol Chem 275:6014–6021

Eude I, Dallot E, Ferre F, Breuiller-Fouche M (2002) Protein kinase Calpha is required for endothelin-1-induced proliferation of human myometrial cells. Biol Reprod 66:44–49

Mochly-Rosen D, Gordon AS (1998) Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J 12:35–42

Jaken S, Parker PJ (2000) Protein kinase C binding partners. Bioessays 22:245–254

Jiffar T, Kurinna S, Suck G et al (2004) PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation. Leukemia 18:505–512

Spitaler M, Wiesenhofer B, Biedermann V et al (1999) The involvement of protein kinase C isoenzymes alpha, epsilon and zeta in the sensitivity to antitumor treatment and apoptosis induction. Anticancer Res 19:3969–3976

Nguyen M, Millar DG, Yong VW, Korsmeyer SJ, Shore GC (1993) Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J Biol Chem 268:25265–25268

Ruvolo PP, Deng X, Carr BK, May WS (1998) A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 273:25436–25442

Borner C (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39:615–647

Poole AW, Pula G, Hers I, Crosby D, Jones ML (2004) PKC-interacting proteins: from function to pharmacology. Trends Pharmacol Sci 25:528–535

Lee HS, Millward-Sadler SJ, Wright MO, Nuki G, Al-Jamal R, Salter DM (2002) Activation of Integrin-RACK1/PKCalpha signalling in human articular chondrocyte mechanotransduction. Osteoarthritis Cartilage 10:890–897

Perez JL, Khatri L, Chang C, Srivastava S, Osten P, Ziff EB (2001) PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2. J Neurosci 21:5417–5428

Wang WL, Yeh SF, Chang YI et al (2003) PICK1, an anchoring protein that specifically targets protein kinase Calpha to mitochondria selectively upon serum stimulation in NIH 3T3 cells. J Biol Chem 278:37705–37712

Staudinger J, Zhou J, Burgess R, Elledge SJ, Olson EN (1995) PICK1: a perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system. J Cell Biol 128:263–271

Staudinger J, Lu J, Olson EN (1997) Specific interaction of the PDZ domain protein PICK1 with the COOH terminus of protein kinase C-alpha. J Biol Chem 272:32019–32024

Dev KK (2004) Making protein interactions druggable: targeting PDZ domains. Nat Rev Drug Discov 3:1047–1056

Lin WJ, Chang YF, Wang WL, Huang CY (2001) Mitogen-stimulated TIS21 protein interacts with a protein-kinase-Calpha-binding protein rPICK1. Biochem J 354:635–643

Takeya R, Takeshige K, Sumimoto H (2000) Interaction of the PDZ domain of human PICK1 with class I ADP-ribosylation factors. Biochem Biophys Res Commun 267:149–155

Chang CD, Meienhofer J (1978) Solid-phase peptide synthesis using mild base cleavage of N alpha-fluorenylmethyloxycarbonylamino acids, exemplified by a synthesis of dihydrosomatostatin. Int J Pept Protein Res 11:246–249

Smyth PG, Berman SA (2002) Markers of apoptosis: methods for elucidating the mechanism of apoptotic cell death from the nervous system. Biotechniques 32:648–650, 652, 654

Madsen KL, Beuming T, Niv MY et al (2005) Molecular determinants for the complex binding specificity of the PDZ domain in PICK1. J Biol Chem 280:20539–20548

Fawell S, Seery J, Daikh Y et al (1994) Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 91:664–668

Martiny-Baron G, Kazanietz MG, Mischak H et al (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194–9197

Degterev A, Boyce M, Yuan J (2003) A decade of caspases. Oncogene 22:8543–8567

Sohn D, Schulze-Osthoff K, Janicke RU (2005) Caspase-8 can be activated by interchain proteolysis without receptor-triggered dimerization during drug-induced apoptosis. J Biol Chem 280:5267–5273

Deng X, Kornblau SM, Ruvolo PP, May WS Jr (2001) Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance. J Natl Cancer Inst Monogr 28:30–37

Ito T, Deng X, Carr B, May WS (1997) Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272:11671–11673

Romano MF, Avellino R, Petrella A, Bisogni R, Romano S, Venuta S (2004) Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells. Eur J Cancer 40:2829–2836

Brichese L, Barboule N, Heliez C, Valette A (2002) Bcl-2 phosphorylation and proteasome-dependent degradation induced by paclitaxel treatment: consequences on sensitivity of isolated mitochondria to Bid. Exp Cell Res 278:101–111

Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC (2000) Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 345(2):271–278

Antonsson B, Montessuit S, Sanchez B, Martinou JC (2001) Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 276:11615–11623

Langeberg LK, Scott JD (2005) A-kinase-anchoring proteins. J Cell Sci 118:3217–3220

Dell’Acqua ML, Dodge KL, Tavalin SJ, Scott JD (2002) Mapping the protein phosphatase-2B anchoring site on AKAP79. Binding and inhibition of phosphatase activity are mediated by residues 315–360. J Biol Chem 277:48796–48802

Dev KK, Nakajima Y, Kitano J, Braithwaite SP, Henley JM, Nakanishi S (2000) PICK1 interacts with and regulates PKC phosphorylation of mGLUR7. J Neurosci 20:7252–7257

Mahajan NP, Linder K, Berry G, Gordon GW, Heim R, Herman B (1998) Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer. Nat Biotechnol 16:547–552

Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619

Mikhailov V, Mikhailova M, Pulkrabek DJ, Dong Z, Venkatachalam MA, Saikumar P (2001) Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 276:18361–18374

Wilson-Annan J, O’Reilly LA, Crawford SA et al (2003) Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol 162:877–887

Cory S, Huang DC, Adams JM (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590–8607

Yamamoto K, Ichijo H, Korsmeyer SJ (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19:8469–8478

Blagosklonny MV, Giannakakou P, el-Deiry WS et al (1997) Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res 57:130–135

Halestrap AP, McStay GP, Clarke SJ (2002) The permeability transition pore complex: another view. Biochimie 84:153–166

Boudin H, Craig AM (2001) Molecular determinants for PICK1 synaptic aggregation and mGluR7a receptor coclustering: role of the PDZ, coiled-coil, and acidic domains. J Biol Chem 276:30270–30276

Nourry C, Grant SG, Borg JP (2003) PDZ domain proteins: plug and play! Sci STKE 2003:RE7

Doyle DA, Lee A, Lewis J, Kim E, Sheng M, MacKinnon R (1996) Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 85:1067–1076

Lahn M, Su C, Li S et al (2004) Expression levels of protein kinase C-alpha in non-small-cell lung cancer. Clin Lung Cancer 6:184–189

Gravitt KR, Ward NE, Fan D, Skibber JM, Levin B, O’Brian CA (1994) Evidence that protein kinase C-alpha activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells. Biochem Pharmacol 48:375–381

Mandil R, Ashkenazi E, Blass M et al (2001) Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res 61:4612–4619

Leirdal M, Sioud M (1999) Ribozyme inhibition of the protein kinase C alpha triggers apoptosis in glioma cells. Br J Cancer 80:1558–1564

Hanauske AR, Sundell K, Lahn M (2004) The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen. Curr Pharm Des 10:1923–1936